Which of the following best describes the role of biotechnology in gene expression?

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

Biotechnology encompasses a suite of laboratory techniques that manipulate nucleic acids and gene expression at the molecular level. Central to this discipline is recombinant DNA technology—the insertion of a target gene into a plasmid vector via restriction endonucleases (e.g., EcoRI cutting at GAATTC palindromic sequences) and DNA ligase forming phosphodiester bonds between the vector backbone and the insert. Once a plasmid like pUC19 is introduced into Escherichia coli through transformation, the bacterial RNA polymerase transcribes the inserted gene from an inducible promoter such as lacUV5 or T7. Translation then follows on 70S ribosomes, producing a protein—perhaps human insulin (INS gene product)—that folds under the governance of hydrogen bonding, hydrophobic interactions between nonpolar R groups burying into the interior of the protein, and disulfide bridge formation between cysteine residues. This cascade of molecular events demonstrates that biotechnological methods allow researchers to harness transcriptional and translational machinery to produce structurally precise, functional proteins that can sustain biological system integrity, from membrane receptor geometry to enzymatic active-site architecture.

Why Other Options Are Wrong

Polymerase chain reaction (PCR) further illustrates biotechnology's deep molecular engagement with gene expression. Taq polymerase, isolated from Thermus aquaticus and thermostable due to a high proportion of ionic salt bridges and compact hydrophobic core packing, extends primers annealed to single-stranded template DNA during repeated cycles of denaturation at 95°C (disrupting hydrogen bonds between complementary nitrogenous bases), primer annealing at 55–65°C, and extension at 72°C. Gel electrophoresis exploits the uniform negative charge carried by phosphate groups along the DNA backbone; fragments migrate toward the anode through an agarose matrix at rates inversely proportional to their molecular mass, enabling visualization of amplicons and verification of expression constructs. CRISPR-Cas9 gene editing introduces double-strand breaks at precise loci determined by guide-RNA (gRNA) complementarity, leveraging the cell's non-homologous end joining (NHEJ) or homology-directed repair (HDR) pathways to disrupt, correct, or insert sequences that modify gene expression patterns.

PILLAR 2 — STEP-BY-STEP LOGIC

The correct answer, Option B, states that biotechnology "is essential for the structural integrity and function of biological systems." This phrasing, while broad, captures the fundamental capacity of biotechnological tools to ensure that the proteins, enzymes, and structural macromolecules produced through gene expression maintain their proper conformation and therefore their biological activity. Consider the production of recombinant Factor VIII for hemophilia patients: without biotechnology, this clotting factor—whose tertiary structure depends on precise disulfide bonds between cysteine residues and correct glycosylation patterns established in the endoplasmic reticulum and Golgi apparatus—could not be manufactured at clinical scale. Similarly, the creation of Golden Rice via insertion of the psy (phytoene synthase) and crtI (phytoene desaturase) genes into the rice genome enables β-carotene production in endosperm tissue, directly linking biotechnology to functional metabolic output that sustains organismal health. The question asks which description "best" fits biotechnology's role in gene expression; among the choices provided, Option B most accurately reflects that biotechnology enables the controlled production, analysis, and engineering of the molecules that give biological systems their structural framework and operational capability. Gene expression, read through the lens of the central dogma (DNA → pre-mRNA → mRNA → polypeptide → functional protein), depends on accurate transcription initiation at promoter sequences, correct RNA splicing removing introns via spliceosomal small nuclear ribonucleoproteins (snRNPs), and translation fidelity ensured by aminoacyl-tRNA synthetases that charge tRNAs with cognate amino acids. Biotechnology leverages every step of this information flow.

PILLAR 3 — DISTRACTOR ANALYSIS

Option A traps students who conflate biotechnology with endogenous gene regulation. Feedback mechanisms—such as the trp operon's attenuation, where tryptophan-bound trp repressor binds the operator sequence to block RNA polymerase transcription of trpE, trpD, trpC, trpB, and trpA—are internal cellular control circuits, not biotechnological applications. The error lies in confusing the study of regulation with the regulatory mechanism itself.

Option C appeals to students who associate biotechnology loosely with biological processes without attending to precision. The main energy source for metabolic reactions is ATP, synthesized through chemiosmosis in mitochondria (oxidative phosphorylation via ATP synthase coupled to the proton gradient across the inner mitochondrial membrane) or in chloroplasts (photophosphorylation driven by light-dependent proton pumping into the thylakoid lumen). Biotechnology manipulates nucleic acids and gene expression, not energy currency.

Option D lures students who think of biotechnology in terms of maintaining equilibrium. Buffering and homeostasis involve physiological mechanisms—bicarbonate buffering of blood pH, insulin/glucagon regulation of blood glucose through pancreatic alpha and beta cells, or kidney nephron reabsorption via sodium-potassium ATPase pumps establishing electrochemical gradients. These are autonomous regulatory phenomena distinct from the deliberate, human-engineered manipulation of genetic material that defines biotechnology.